Although we analysed 40 clinical CRC samples, revealing positive correlations among H3K18la, IGF2BP2 and Nrf2 and were further supported by bioinformatic data from larger cohorts, the sample size remains relatively modest. This evidence concerns the gene IGF2BP2 and colorectal carcinoma.